世界の診断用特殊抗体市場2020年ー2027年:種類別(モノクローナル抗体、ポリクローナル抗体、その他)、用途別、エンドユーザー別、地域別

◆英語タイトル:Global Diagnostic Specialty Antibodies Market Size study, by Type (Monoclonal Antibodies, Polyclonal Antibodies, Others), by Application (Oncology Diagnosis, Hepatitis Diagnosis, Infectious Disease Diagnosis, Others), by End-User (Diagnostic Laboratories, Hospitals) and Regional Forecasts 2020-2027
◆商品コード:BZW21FB005
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2021年1月20日
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:米国、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、GCC諸国
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥564,300見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥712,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

Bizwit Research社の本調査資料では、世界の診断用特殊抗体市場を広く調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、種類別(モノクローナル抗体、ポリクローナル抗体、その他)分析、用途別(腫瘍診断、肝炎診断、感染症診断、その他)分析、エンドユーザー別(診断研究所、病院)分析、地域別分析、競争状況、調査プロセスなど、以下の構成でまとめております。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・世界の診断用特殊抗体市場規模:種類別(モノクローナル抗体、ポリクローナル抗体、その他)
・世界の診断用特殊抗体市場規模:用途別(腫瘍診断、肝炎診断、感染症診断、その他)
・世界の診断用特殊抗体市場規模:エンドユーザー別(診断研究所、病院)
・世界の診断用特殊抗体市場規模:地域別
・競争状況
・調査プロセス
【レポートの概要】

Global Diagnostic Specialty Antibodies Market is valued at approximately USD 19.6 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 3.0% over the forecast period 2020-2027. Antibodies are the part of blood proteins that produced in response to a certain antigen. They are usually known as immunoglobulin and are generally in the shape of the Y structure. These antibodies are effectual and increase the binding capacity of any sort of certain antigen. Further, the advancements in technology, particularly in the genetic engineering field help introduce numerous antibodies, that are frequently monoclonal antibodies. These are additionally effectual and robust that can help in the betterment of the capacity of binding to an antigen. Also, these antibodies have demonstrated to be effective as diagnostic tools for the assessment and testing of numerous infectious diseases. Thus, the rise in prevalence of infectious, such as HIV/AIDS, along with growing R&D expenditure in the pharmaceutical and biopharmaceutical companies are the few factors responsible for the CAGR of the market during the forecast period. According to the Avert organization, roughly 37.9 million individuals were affected by HIV (including 1.7 million children) in 2018, with a global HIV prevalence of 0.8% in the adult population. Similarly, the U.S. Department of Health & Human Services estimated that about 21.7 million people living with HIV in 2017, representing an increase of 2.3 million from 2016 and 8 million since 2010. This, in turn, is expected to strengthen the market growth all over the world. In addition, the demand for diagnostic specialty antibodies has decreased recently due to the concerns faced considering antibodies that are not capable to operate a precise and smooth diagnostic test for regular diagnosis, which may limit the market growth around the world. However, the high cost of the development of diagnostic specialty antibodies is one of the major factors restraining market growth over the forecast period of 2020-2027.

The regional analysis of the global Diagnostic Specialty Antibodies market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rise in prevalence of infectious diseases and life-threatening diseases, along with the significant presence of market vendors in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in pharmaceutical and biopharmaceutical expenditure, along with the rise in government programs concerning diseases treatment and improving healthcare infrastructure in developing countries, such as China and India, would create lucrative growth prospects for the Diagnostic Specialty Antibodies market across the Asia-Pacific region.

Major market player included in this report are:
F. Hoffmann-La Roche AG
Abbott Laboratories
Abcam plc
Bio-Rad Laboratories, Inc.
Agilent Technologies, Inc.
Creative Diagnostics
Thermo Fisher Scientific Inc.
Becton, Dickinson and Company
Merck KGaA
Sartorius AG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Monoclonal Antibodies
Polyclonal Antibodies
Others

By Application:
Oncology Diagnosis
Hepatitis Diagnosis
Infectious Disease Diagnosis
Others

By End-User:
Diagnostic Laboratories
Hospitals

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Diagnostic Specialty Antibodies Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Diagnostic Specialty Antibodies Market, by Region, 2018-2027 (USD Billion)
1.2.2. Diagnostic Specialty Antibodies Market, by Type, 2018-2027 (USD Billion)
1.2.3. Diagnostic Specialty Antibodies Market, by Application, 2018-2027 (USD Billion)
1.2.4. Diagnostic Specialty Antibodies Market, by End-User, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Diagnostic Specialty Antibodies Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Diagnostic Specialty Antibodies Market Dynamics
3.1. Diagnostic Specialty Antibodies Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Diagnostic Specialty Antibodies Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Diagnostic Specialty Antibodies Market, by Type
5.1. Market Snapshot
5.2. Global Diagnostic Specialty Antibodies Market by Type, Performance – Potential Analysis
5.3. Global Diagnostic Specialty Antibodies Market Estimates & Forecasts by Type 2017-2027 (USD Billion)
5.4. Diagnostic Specialty Antibodies Market, Sub Segment Analysis
5.4.1. Monoclonal Antibodies
5.4.2. Polyclonal Antibodies
5.4.3. Others
Chapter 6. Global Diagnostic Specialty Antibodies Market, by Application
6.1. Market Snapshot
6.2. Global Diagnostic Specialty Antibodies Market by Application, Performance – Potential Analysis
6.3. Global Diagnostic Specialty Antibodies Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
6.4. Diagnostic Specialty Antibodies Market, Sub Segment Analysis
6.4.1. Oncology Diagnosis
6.4.2. Hepatitis Diagnosis
6.4.3. Infectious Disease Diagnosis
6.4.4. Others
Chapter 7. Global Diagnostic Specialty Antibodies Market, by End-User
7.1. Market Snapshot
7.2. Global Diagnostic Specialty Antibodies Market by End-User – Potential Analysis
7.3. Global Diagnostic Specialty Antibodies Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)
7.4. Diagnostic Specialty Antibodies Market, Sub Segment Analysis
7.4.1. Diagnostic Laboratories
7.4.2. Hospitals
Chapter 8. Global Diagnostic Specialty Antibodies Market, Regional Analysis
8.1. Diagnostic Specialty Antibodies Market, Regional Market Snapshot
8.2. North America Diagnostic Specialty Antibodies Market
8.2.1. U.S. Diagnostic Specialty Antibodies Market
8.2.1.1. Type breakdown estimates & forecasts, 2017-2027
8.2.1.2. Application breakdown estimates & forecasts, 2017-2027
8.2.1.3. End-User breakdown estimates & forecasts, 2017-2027
8.2.2. Canada Diagnostic Specialty Antibodies Market
8.3. Europe Diagnostic Specialty Antibodies Market Snapshot
8.3.1. U.K. Diagnostic Specialty Antibodies Market
8.3.2. Germany Diagnostic Specialty Antibodies Market
8.3.3. France Diagnostic Specialty Antibodies Market
8.3.4. Spain Diagnostic Specialty Antibodies Market
8.3.5. Italy Diagnostic Specialty Antibodies Market
8.3.6. Rest of Europe Diagnostic Specialty Antibodies Market
8.4. Asia-Pacific Diagnostic Specialty Antibodies Market Snapshot
8.4.1. China Diagnostic Specialty Antibodies Market
8.4.2. India Diagnostic Specialty Antibodies Market
8.4.3. Japan Diagnostic Specialty Antibodies Market
8.4.4. Australia Diagnostic Specialty Antibodies Market
8.4.5. South Korea Diagnostic Specialty Antibodies Market
8.4.6. Rest of Asia Pacific Diagnostic Specialty Antibodies Market
8.5. Latin America Diagnostic Specialty Antibodies Market Snapshot
8.5.1. Brazil Diagnostic Specialty Antibodies Market
8.5.2. Mexico Diagnostic Specialty Antibodies Market
8.6. Rest of The World Diagnostic Specialty Antibodies Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. F. Hoffmann-La Roche AG
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Abbott Laboratories
9.2.3. Abcam plc
9.2.4. Bio-Rad Laboratories, Inc.
9.2.5. Agilent Technologies, Inc.
9.2.6. Creative Diagnostics
9.2.7. Thermo Fisher Scientific Inc.
9.2.8. Becton, Dickinson and Company
9.2.9. Merck KGaA
9.2.10. Sartorius AG
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

List of Tables
TABLE 1. Global Diagnostic Specialty Antibodies market, report scope
TABLE 2. Global Diagnostic Specialty Antibodies market estimates & forecasts by region 2017-2027 (USD Billion)
TABLE 3. Global Diagnostic Specialty Antibodies market estimates & forecasts by Type 2017-2027 (USD Billion)
TABLE 4. Global Diagnostic Specialty Antibodies market estimates & forecasts by Application 2017-2027 (USD Billion)
TABLE 5. Global Diagnostic Specialty Antibodies market estimates & forecasts by End-User 2017-2027 (USD Billion)
TABLE 6. Global Diagnostic Specialty Antibodies market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 7. Global Diagnostic Specialty Antibodies market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 8. Global Diagnostic Specialty Antibodies market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 9. Global Diagnostic Specialty Antibodies market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 10. Global Diagnostic Specialty Antibodies market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 11. Global Diagnostic Specialty Antibodies market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 12. Global Diagnostic Specialty Antibodies market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 13. Global Diagnostic Specialty Antibodies market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 14. Global Diagnostic Specialty Antibodies market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 15. Global Diagnostic Specialty Antibodies market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 16. Global Diagnostic Specialty Antibodies market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 17. Global Diagnostic Specialty Antibodies market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 18. Global Diagnostic Specialty Antibodies market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 19. Global Diagnostic Specialty Antibodies market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 20. Global Diagnostic Specialty Antibodies market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 21. Global Diagnostic Specialty Antibodies market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 22. U.S. Diagnostic Specialty Antibodies market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 23. U.S. Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 24. U.S. Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 25. Canada Diagnostic Specialty Antibodies market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 26. Canada Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 27. Canada Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 28. UK Diagnostic Specialty Antibodies market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 29. UK Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 30. UK Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 31. Germany Diagnostic Specialty Antibodies market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 32. Germany Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 33. Germany Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 34. France Diagnostic Specialty Antibodies market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 35. France Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 36. France Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 37. Spain Diagnostic Specialty Antibodies market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 38. Spain Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 39. Spain Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 40. Italy Diagnostic Specialty Antibodies market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 41. Italy Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 42. Italy Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 43. ROE Diagnostic Specialty Antibodies market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 44. ROE Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 45. ROE Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 46. China Diagnostic Specialty Antibodies market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 47. China Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 48. China Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 49. India Diagnostic Specialty Antibodies market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 50. India Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 51. India Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 52. Japan Diagnostic Specialty Antibodies market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 53. Japan Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 54. Japan Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 55. Australia Diagnostic Specialty Antibodies market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 56. Australia Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 57. Australia Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 58. South Korea Diagnostic Specialty Antibodies market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 59. South Korea Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 60. South Korea Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 61. ROPAC Diagnostic Specialty Antibodies market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 62. ROPAC Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 63. ROPAC Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 64. Brazil Diagnostic Specialty Antibodies market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 65. Brazil Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 66. Brazil Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 67. Mexico Diagnostic Specialty Antibodies market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 68. Mexico Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 69. Mexico Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 70. ROLA Diagnostic Specialty Antibodies market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 71. ROLA Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 72. ROLA Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 73. ROW Diagnostic Specialty Antibodies market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 74. ROW Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 75. ROW Diagnostic Specialty Antibodies market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 76. List of secondary sources, used in the study of global Diagnostic Specialty Antibodies market
TABLE 77. List of primary sources, used in the study of global Diagnostic Specialty Antibodies market
TABLE 78. Years considered for the study
TABLE 79. Exchange rates considered

List of figures
FIG 1. Global Diagnostic Specialty Antibodies market, research methodology
FIG 2. Global Diagnostic Specialty Antibodies market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Diagnostic Specialty Antibodies market, key trends 2019
FIG 5. Global Diagnostic Specialty Antibodies market, growth prospects 2020-2027
FIG 6. Global Diagnostic Specialty Antibodies market, porters 5 force Model
FIG 7. Global Diagnostic Specialty Antibodies market, pest analysis
FIG 8. Global Diagnostic Specialty Antibodies market, value chain analysis
FIG 9. Global Diagnostic Specialty Antibodies market by segment, 2017 & 2027 (USD Billion)
FIG 10. Global Diagnostic Specialty Antibodies market by segment, 2017 & 2027 (USD Billion)
FIG 11. Global Diagnostic Specialty Antibodies market by segment, 2017 & 2027 (USD Billion)
FIG 12. Global Diagnostic Specialty Antibodies market by segment, 2017 & 2027 (USD Billion)
FIG 13. Global Diagnostic Specialty Antibodies market by segment, 2017 & 2027 (USD Billion)
FIG 14. Global Diagnostic Specialty Antibodies market by segment, 2017 & 2027 (USD Billion)
FIG 15. Global Diagnostic Specialty Antibodies market by segment, 2017 & 2027 (USD Billion)
FIG 16. Global Diagnostic Specialty Antibodies market by segment, 2017 & 2027 (USD Billion)
FIG 17. Global Diagnostic Specialty Antibodies market, regional snapshot 2017 & 2027
FIG 18. North America Diagnostic Specialty Antibodies market 2017 & 2027 (USD Billion)
FIG 19. Europe Diagnostic Specialty Antibodies market 2017 & 2027 (USD Billion)
FIG 20. Asia-Pacific Diagnostic Specialty Antibodies market 2017 & 2027 (USD Billion)
FIG 21. Latin America Diagnostic Specialty Antibodies market 2017 & 2027 (USD Billion)
FIG 22. Global Diagnostic Specialty Antibodies market, company market share analysis (2019)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の診断用特殊抗体市場2020年ー2027年:種類別(モノクローナル抗体、ポリクローナル抗体、その他)、用途別、エンドユーザー別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆